Caseware UK (AP4) 2024.0.164 2024.0.164 2025-12-312025-12-312025-12-31falsefalse2024-07-01falseTrading in pharmaceutical goods2020false 11359129 2024-07-01 2025-12-31 11359129 2023-07-01 2024-06-30 11359129 2025-12-31 11359129 2024-06-30 11359129 2023-07-01 11359129 1 2024-07-01 2025-12-31 11359129 d:Director1 2024-07-01 2025-12-31 11359129 d:RegisteredOffice 2024-07-01 2025-12-31 11359129 c:Buildings c:LongLeaseholdAssets 2024-07-01 2025-12-31 11359129 c:Buildings c:LongLeaseholdAssets 2025-12-31 11359129 c:Buildings c:LongLeaseholdAssets 2024-06-30 11359129 c:LandBuildings 2025-12-31 11359129 c:LandBuildings 2024-06-30 11359129 c:PlantMachinery 2024-07-01 2025-12-31 11359129 c:PlantMachinery 2025-12-31 11359129 c:PlantMachinery 2024-06-30 11359129 c:PlantMachinery c:OwnedOrFreeholdAssets 2024-07-01 2025-12-31 11359129 c:MotorVehicles 2024-07-01 2025-12-31 11359129 c:OtherPropertyPlantEquipment 2024-07-01 2025-12-31 11359129 c:OwnedOrFreeholdAssets 2024-07-01 2025-12-31 11359129 c:PatentsTrademarksLicencesConcessionsSimilar 2024-07-01 2025-12-31 11359129 c:PatentsTrademarksLicencesConcessionsSimilar 2025-12-31 11359129 c:PatentsTrademarksLicencesConcessionsSimilar 2024-06-30 11359129 c:CurrentFinancialInstruments 2025-12-31 11359129 c:CurrentFinancialInstruments 2024-06-30 11359129 c:CurrentFinancialInstruments c:WithinOneYear 2025-12-31 11359129 c:CurrentFinancialInstruments c:WithinOneYear 2024-06-30 11359129 c:ShareCapital 2024-07-01 2025-12-31 11359129 c:ShareCapital 2025-12-31 11359129 c:ShareCapital 2023-07-01 2024-06-30 11359129 c:ShareCapital 2024-06-30 11359129 c:ShareCapital 2023-07-01 11359129 c:ForeignCurrencyTranslationReserve 2024-07-01 2025-12-31 11359129 c:RetainedEarningsAccumulatedLosses 2024-07-01 2025-12-31 11359129 c:RetainedEarningsAccumulatedLosses 2025-12-31 11359129 c:RetainedEarningsAccumulatedLosses 2023-07-01 2024-06-30 11359129 c:RetainedEarningsAccumulatedLosses 2024-06-30 11359129 c:RetainedEarningsAccumulatedLosses 2023-07-01 11359129 d:OrdinaryShareClass1 2024-07-01 2025-12-31 11359129 d:OrdinaryShareClass1 2025-12-31 11359129 d:OrdinaryShareClass1 2024-06-30 11359129 d:FRS102 2024-07-01 2025-12-31 11359129 d:Audited 2024-07-01 2025-12-31 11359129 d:FullAccounts 2024-07-01 2025-12-31 11359129 d:PrivateLimitedCompanyLtd 2024-07-01 2025-12-31 11359129 c:Subsidiary1 2025-12-31 11359129 c:Subsidiary1 2024-07-01 2025-12-31 11359129 c:Subsidiary1 1 2024-07-01 2025-12-31 11359129 c:Subsidiary2 2025-12-31 11359129 c:Subsidiary2 2024-07-01 2025-12-31 11359129 c:Subsidiary2 1 2024-07-01 2025-12-31 11359129 d:Consolidated 2025-12-31 11359129 d:ConsolidatedGroupCompanyAccounts 2024-07-01 2025-12-31 11359129 c:PatentsTrademarksLicencesConcessionsSimilar c:ExternallyAcquiredIntangibleAssets 2024-07-01 2025-12-31 11359129 6 2024-07-01 2025-12-31 11359129 c:PatentsTrademarksLicencesConcessionsSimilar c:OwnedIntangibleAssets 2024-07-01 2025-12-31 11359129 e:Euro 2024-07-01 2025-12-31 11359129 c:PreviouslyStatedAmount 2024-06-30 11359129 c:Buildings c:LongLeaseholdAssets c:PreviouslyStatedAmount 2024-06-30 11359129 c:PlantMachinery c:PreviouslyStatedAmount 2024-06-30 xbrli:shares iso4217:GBP xbrli:pure

Registered number: 11359129









AMAXA LTD









ANNUAL REPORT AND AUDITED FINANCIAL STATEMENTS

FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

 
AMAXA LTD
 
 
COMPANY INFORMATION


Director
Jane Tkachenko 




Registered number
11359129



Registered office
31 John Islip Street

London

United Kingdom

SW1P 4FE




Independent auditors
Zenith Audit Ltd
Statutory Auditors

3rd Floor North,

Warwick House, 65/66 Queen Street

London

EC4R 1EB





 
AMAXA LTD
 

CONTENTS



Page
Group Strategic Report
1
Director's Report
2 - 3
Independent Auditors' Report
4 - 7
Consolidated Statement of Comprehensive Income
8
Consolidated Balance Sheet
9
Company Balance Sheet
10
Consolidated Statement of Changes in Equity
11 - 12
Company Statement of Changes in Equity
13 - 14
Consolidated Statement of Cash Flows
15
Consolidated Analysis of Net Debt
16
Notes to the Financial Statements
17 - 37


 
AMAXA LTD
 
 
GROUP STRATEGIC REPORT
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

Introduction
 
The director presents her report together with the financial statement for the 18 months ending 31 December 2025.

Business review
 
The Group is engaged in the marketing and supply of proprietory pharmaceutical goods in overseas markets. Products are sourced from manufacturers overseas and marketed, sold and transported by the Group to the relevant overseas markets. 

Principal risks and uncertainties
 
The operating environment for the Group remains challenging due to the volatile political situation in Eastern Europe. 
This instability contributes to currency fluctuations in relevant markets, posing a risk as transactions are conducted in local currencies. Unfavourable shifts in exchange rates could result in associated losses.
 
Another uncertainty is the potential impact of government-imposed price caps on certain products, which could negatively affect the company’s sales margins.
These risks add to the overall challenges within the business environment in which the Group operates.

Financial key performance indicators
 
The Group's turnover increased by 5.5% in the 12 months of the calendar year ending on 31 December 2025 compared to the 12 months of the calendar year ending on 31 December 2024, rising from €16,574,316 to €17,486,146.


This report was approved by the board on 21 July 2026 and signed on its behalf.



Jane Tkachenko
Director

Page 1

 
AMAXA LTD
 
 
 
DIRECTOR'S REPORT
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

The director presents her report and the financial statements for the 18 months ended 31 December 2025.

Director's responsibilities statement

The director is responsible for preparing the Group Strategic Report, the Director's Report and the consolidated financial statements in accordance with applicable law and regulations.
 
Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland'. Under company law the director must not approve the financial statements unless she is satisfied that they give a true and fair view of the state of affairs of the Company and the Group and of the profit or loss of the Group for that period.

 In preparing these financial statements, the director is required to:


select suitable accounting policies for the Group's financial statements and then apply them consistently;

make judgments and accounting estimates that are reasonable and prudent;

prepare the financial statements on the going concern basis unless it is inappropriate to presume that the Group will continue in business.

The director is responsible for keeping adequate accounting records that are sufficient to show and explain the Company's transactions and disclose with reasonable accuracy at any time the financial position of the Company and the Group and to enable her to ensure that the financial statements comply with the Companies Act 2006She is also responsible for safeguarding the assets of the Company and the Group and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Results and dividends

The profit for the 18 months, after taxation, amounted to 2,603,854 (2024 - 1,399,469).

Director

The director who served during the 18 months was:

Jane Tkachenko 

Future developments

The Group continues to operate normally; however, it remains exposed to risks arising from the ongoing military conflict in Ukraine, which continues to be a significant market. During the year, the Group maintained its strategic focus on expanding into Central Asian markets. This expansion, together with the successful launch of new products and increased market penetration, has contributed to higher levels of business activity and revenue. Other than the risks associated with the conflict in Ukraine, no significant adverse impacts on the Group's operations have been identified during the reporting period.
Looking ahead, the Group expects to achieve growth of approximately 7% in the 2026 calendar year, supported by continued expansion into Central Asian markets and increasing sales of newly launched products.

Page 2

 
AMAXA LTD
 
 
 
DIRECTOR'S REPORT (CONTINUED)
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

Disclosure of information to auditors

The director at the time when this Director's Report is approved has confirmed that:
 
so far as she is aware, there is no relevant audit information of which the Company and the Group's auditors are unaware, and

she has taken all the steps that ought to have been taken as a director in order to be aware of any relevant audit information and to establish that the Company and the Group's auditors are aware of that information.

Auditors

The auditorsZenith Audit Ltdwill be proposed for reappointment in accordance with section 485 of the Companies Act 2006.

This report was approved by the board on 21 July 2026 and signed on its behalf.
 


Jane Tkachenko
Director

Page 3

 
AMAXA LTD
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF AMAXA LTD
 

Opinion


We have audited the financial statements of Amaxa Ltd (the 'Parent Company') and its subsidiaries (the 'Group') for the 18 months ended 31 December 2025, which comprise the Consolidated Statement of Comprehensive Income, the Consolidated Analysis of Net Debt, the Consolidated Balance Sheet, the Company Balance Sheet, the Consolidated Statement of Cash Flows, the Consolidated Statement of Changes in Equity, the Company Statement of Changes in Equity and the related notes, including a summary of significant accounting policiesThe financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).


In our opinion the financial statements:


give a true and fair view of the state of the Group's and of the Parent Company's affairs as at 31 December 2025 and of the Group's profit for the 18 months then ended;
have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and
have been prepared in accordance with the requirements of the Companies Act 2006.


Basis for opinion


We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the Group in accordance with the ethical requirements that are relevant to our audit of the financial statements in the United Kingdom, including the Financial Reporting Council's Ethical Standard and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.


Conclusions relating to going concern


In auditing the financial statements, we have concluded that the director's use of the going concern basis of accounting in the preparation of the financial statements is appropriate.


Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the Group's or the Parent Company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.


Our responsibilities and the responsibilities of the director with respect to going concern are described in the relevant sections of this report.


Page 4

 
AMAXA LTD
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF AMAXA LTD (CONTINUED)


Other information


The other information comprises the information included in the Annual Report other than the financial statements and our Auditors' Report thereon. The director is responsible for the other information contained within the Annual ReportOur opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.


We have nothing to report in this regard.


Opinion on other matters prescribed by the Companies Act 2006
 

In our opinion, based on the work undertaken in the course of the audit:


the information given in the Group Strategic Report and the Director's Report for the financial 18 months for which the financial statements are prepared is consistent with the financial statements; and
the Group Strategic Report and the Director's Report have been prepared in accordance with applicable legal requirements.


Matters on which we are required to report by exception
 

In the light of the knowledge and understanding of the Group and the Parent Company and its environment obtained in the course of the audit, we have not identified material misstatements in the Group Strategic Report or the Director's Report.


We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:


adequate accounting records have not been kept by the Parent Company, or returns adequate for our audit have not been received from branches not visited by us; or
the Parent Company financial statements are not in agreement with the accounting records and returns; or
certain disclosures of director's remuneration specified by law are not made; or
we have not received all the information and explanations we require for our audit.


Page 5

 
AMAXA LTD
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF AMAXA LTD (CONTINUED)


Responsibilities of directors
 

As explained more fully in the Director's Responsibilities Statement set out on page 2, the director is responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the director determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error.


In preparing the financial statements, the director is responsible for assessing the Group's and the Parent Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the director either intends to liquidate the Group or the Parent Company or to cease operations, or has no realistic alternative but to do so.


Auditors' responsibilities for the audit of the financial statements
 

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an Auditors' Report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these Group financial statements.


Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

We performed risk assessment procedures and obtained an understanding of the Company and its environment, the applicable financial reporting framework, the applicable laws and regulations, the Company's system of internal control and the fraud risk factors relevant to the Company that affect the susceptibility of assertions to material misstatement due to fraud. We made enquiries with management regarding actual or suspected fraud, non-compliance with laws and regulations, potential litigation and claims. The engagement partner led a discussion among the audit team with particular emphasis on how and where the Company's financial statements may be susceptible to material misstatement due to fraud, including how fraud might occur. The engagement partner assessed that the engagement team collectively had the appropriate competence and capability to identify or recognise non-compliance with laws and regulations.
We considered compliance with UK Companies Act 2006, and the applicable tax legislation as the key laws and regulations which non-compliance could directly lead to material misstatement due to fraud at the financial statement level. We evaluated whether the selection and application of accounting policies by the Company may be indicative of fraudulent financial reporting. Our audit procedures responsive to assessed risks of material misstatement due to fraud at the assertion level included but were not limited to:
- Testing the appropriateness of manual journal entries recorded in the general ledger and other adjustments made in the preparation of the financial statements;
- Making inquiries of individuals involved in the financial reporting process about inappropriate or unusual activity relating to the processing of journal entries;
- Selecting and testing journal entries and other adjustments made at the end of a reporting period and throughout the period;
- Reviewing accounting estimates for biases that could represent a risk of material misstatement due to fraud.


 
Page 6

 
AMAXA LTD
 
 
 
INDEPENDENT AUDITORS' REPORT TO THE MEMBERS OF AMAXA LTD (CONTINUED)


Owing to the inherent limitations of an audit, there is an unavoidable risk that some material misstatements of the financial statements due to irregularities, including fraud, may not be detected, even though we have properly planned and performed our audit in accordance with the auditing standards. For example, the further removed non-compliance with laws and regulations is from the events and transactions reflected in the financial statements, the less likely we would become aware of it. In addition, as with any audit, there remains a higher risk of non-detection of irregularities, as they may involve collusion, forgery, intentional omissions and override of internal controls.


A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council's website at: www.frc.org.uk/auditorsresponsibilities. This description forms part of our Auditors' Report.


Use of our report
 

This report is made solely to the Company's members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006Our audit work has been undertaken so that we might state to the Company's members those matters we are required to state to them in an Auditors' Report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company and the Company's members, as a body, for our audit work, for this report, or for the opinions we have formed.





Milena Mitova (Senior Statutory Auditor)
  
for and on behalf of
Zenith Audit Ltd
 
Statutory Auditors
  
3rd Floor North,
Warwick House, 65/66 Queen Street
London
EC4R 1EB

21 July 2026
Page 7

 
AMAXA LTD
 
 
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

18 months ending 31 December
30 June
2025
2024
Note

  

Turnover
 4 
27,308,415
15,888,430

Cost of sales
  
(13,840,331)
(7,959,713)

Gross profit
  
13,468,084
7,928,717

Administrative expenses
  
(9,959,573)
(6,011,609)

Other operating income
 5 
27,898
7,517

Other operating charges
  
-
(8,561)

Operating profit
 6 
3,536,409
1,916,064

Amounts written off investments
  
-
(2,321)

Interest payable and similar expenses
 10 
-
(12,131)

Profit before taxation
  
3,536,409
1,901,612

Tax on profit
 11 
(932,555)
(502,143)

Profit for the financial 18 months
  
2,603,854
1,399,469

  

Currency translation differences
  
15,002
25,950

Other comprehensive income for the 18 months
  
15,002
25,950

Total comprehensive income for the 18 months
  
2,618,856
1,425,419

Profit for the 18 months attributable to:
  

Owners of the parent Company
  
2,603,854
1,399,469

  
2,603,854
1,399,469

Total comprehensive income for the 18 months attributable to:
  

Owners of the parent Company
  
2,618,856
1,425,419

  
2,618,856
1,425,419

The notes on pages 17 to 37 form part of these financial statements.

Page 8

 
AMAXA LTD
REGISTERED NUMBER: 11359129

CONSOLIDATED BALANCE SHEET
AS AT 31 DECEMBER 2025

31 December
30 June
2025
2024
Note

Fixed assets
  

Intangible assets
 14 
44,651
22,894

Tangible assets
 15 
1,030,756
1,155,468

  
1,075,407
1,178,362

Current assets
  

Stocks
 17 
1,165,437
2,363,493

Debtors: amounts falling due within one year
 18 
6,997,198
4,208,393

Cash at bank and in hand
 19 
4,825,338
3,571,490

  
12,987,973
10,143,376

Creditors: amounts falling due within one year
 20 
(1,104,040)
(658,098)

Net current assets
  
 
 
11,883,933
 
 
9,485,278

Total assets less current liabilities
  
12,959,340
10,663,640

Net assets
  
12,959,340
10,663,640


Capital and reserves
  

Called up share capital 
 21 
44,008
44,008

Foreign exchange reserve
 22 
31,135
16,133

Profit and loss account
 22 
12,884,197
10,603,499

Equity attributable to owners of the parent Company
  
12,959,340
10,663,640

  
12,959,340
10,663,640


The financial statements were approved and authorised for issue by the board and were signed on its behalf on 21 July 2026.




Jane Tkachenko
Director

The notes on pages 17 to 37 form part of these financial statements.

Page 9

 
AMAXA LTD
REGISTERED NUMBER: 11359129

COMPANY BALANCE SHEET
AS AT 31 DECEMBER 2025

31 December
30 June
2025
2024
Note

Fixed assets
  

Intangible assets
 14 
44,360
22,577

Tangible assets
 15 
1,024,404
1,155,466

Investments
 16 
1,420
1,420

  
1,070,184
1,179,463

Current assets
  

Stocks
 17 
1,165,116
2,363,493

Debtors: amounts falling due within one year
 18 
7,046,139
4,259,673

Cash at bank and in hand
 19 
4,754,840
3,551,515

  
12,966,095
10,174,681

Creditors: amounts falling due within one year
 20 
(1,055,084)
(706,243)

Net current assets
  
 
 
11,911,011
 
 
9,468,438

Total assets less current liabilities
  
12,981,195
10,647,901

  

  

Net assets excluding pension asset
  
12,981,195
10,647,901

Net assets
  
12,981,195
10,647,901


Capital and reserves
  

Called up share capital 
 21 
44,008
44,008

Profit and loss account
 22 
12,937,187
10,603,893

  
12,981,195
10,647,901


The financial statements were approved and authorised for issue by the board and were signed on its behalf on 21 July 2026.


Jane Tkachenko
Director

The notes on pages 17 to 37 form part of these financial statements.

Page 10

 
AMAXA LTD
 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025


Called up share capital
Foreign exchange reserve
Profit and loss account
Total equity


At 1 July 2024
44,008
16,133
10,603,499
10,663,640


Comprehensive income for the 18 months

Profit for the 18 months

-
-
2,603,854
2,603,854

Currency translation differences
-
15,002
-
15,002


Other comprehensive income for the 18 months
-
15,002
-
15,002


Total comprehensive income for the 18 months
-
15,002
2,603,854
2,618,856


Contributions by and distributions to owners

Dividends: Equity capital
-
-
(323,156)
(323,156)


Total transactions with owners
-
-
(323,156)
(323,156)


At 31 December 2025
44,008
31,135
12,884,197
12,959,340


The notes on pages 17 to 37 form part of these financial statements.

Page 11

 
AMAXA LTD
 

CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
FOR THE 18 MONTHS ENDED 30 JUNE 2024


Called up share capital
Foreign exchange reserve
Profit and loss account
Total equity


At 1 July 2023
44,008
(9,817)
9,550,286
9,584,477


Comprehensive income for the year

Profit for the year

-
-
1,399,469
1,399,469

Currency translation differences
-
25,950
-
25,950


Other comprehensive income for the year
-
25,950
-
25,950


Total comprehensive income for the year
-
25,950
1,399,469
1,425,419


Contributions by and distributions to owners

Dividends: Equity capital
-
-
(346,256)
(346,256)


Total transactions with owners
-
-
(346,256)
(346,256)


At 30 June 2024
44,008
16,133
10,603,499
10,663,640


The notes on pages 17 to 37 form part of these financial statements.

Page 12

 
AMAXA LTD
 

COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025


Called up share capital
Profit and loss account
Total equity


At 1 July 2024
44,008
10,603,893
10,647,901


Comprehensive income for the year

Profit for the 18 months

-
2,656,450
2,656,450


Other comprehensive income for the 18 months
-
-
-


Total comprehensive income for the 18 months
-
2,656,450
2,656,450


Contributions by and distributions to owners

Dividends: Equity capital
-
(323,156)
(323,156)


Total transactions with owners
-
(323,156)
(323,156)


At 31 December 2025
44,008
12,937,187
12,981,195


The notes on pages 17 to 37 form part of these financial statements.

Page 13

 
AMAXA LTD
 

COMPANY STATEMENT OF CHANGES IN EQUITY
FOR THE 18 MONTHS ENDED 30 JUNE 2024


Called up share capital
Profit and loss account
Total equity


At 1 July 2023
44,008
9,536,830
9,580,838


Comprehensive income for the year

Profit for the year

-
1,413,319
1,413,319


Other comprehensive income for the year
-
-
-


Total comprehensive income for the year
-
1,413,319
1,413,319


Contributions by and distributions to owners

Dividends: Equity capital
-
(346,256)
(346,256)


Total transactions with owners
-
(346,256)
(346,256)


At 30 June 2024
44,008
10,603,893
10,647,901


The notes on pages 17 to 37 form part of these financial statements.

Page 14

 
AMAXA LTD
 

CONSOLIDATED STATEMENT OF CASH FLOWS
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

18 months ending 31 December
30 June
2025
2024

Cash flows from operating activities

Profit for the financial 18 months
2,603,854
1,399,469

Adjustments for:

Depreciation of tangible assets
150,792
96,838

Loss on disposal of tangible assets
-
2,321

Interest paid
-
12,131

Taxation charge
932,555
502,143

Decrease/(increase) in stocks
1,198,056
(955,165)

(Increase) in debtors
(2,788,805)
(324,828)

Increase in creditors
261,002
202,219

Corporation tax (paid)
(747,615)
(732,516)

Foreign exchange
15,002
24,194

Net cash generated from operating activities

1,624,841
226,806


Cash flows from investing activities

Purchase of intangible fixed assets
(30,054)
(8,569)

Purchase of tangible fixed assets
(17,783)
(24,195)

Net cash from investing activities

(47,837)
(32,764)

Cash flows from financing activities

Loans from related parties repaid
-
(1,349,111)

Dividends paid
(323,156)
(460,073)

Interest paid
-
(12,131)

Net cash used in financing activities
(323,156)
(1,821,315)

Net increase/(decrease) in cash and cash equivalents
1,253,848
(1,627,273)

Cash and cash equivalents at beginning of 18 months
3,571,490
5,198,763

Cash and cash equivalents at the end of 18 months
4,825,338
3,571,490


Cash at bank and in hand as at the end of the period
4,825,338
3,571,490


The notes on pages 17 to 37 form part of these financial statements.

Page 15

 
AMAXA LTD
 

CONSOLIDATED ANALYSIS OF NET DEBT
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025




At 1 July 2024
Cash flows
At 31 December 2025



Cash at bank and in hand

3,571,490

1,253,848

4,825,338


3,571,490
1,253,848
4,825,338

The notes on pages 17 to 37 form part of these financial statements.

Page 16

 
AMAXA LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

1.


General information

Amaxa Ltd, is a private company limited by shares incorporated in England & Wales. The Group's registered office and registered number are shown on the Company information page. 

2.Accounting policies

 
2.1

Basis of preparation of financial statements for the 18 months ending 31 December 2025

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with Financial Reporting Standard 102, the Financial Reporting Standard applicable in the UK and the Republic of Ireland and the Companies Act 2006.

The preparation of financial statements in compliance with FRS 102 requires the use of certain critical accounting estimates. It also requires Group management to exercise judgment in applying the Group's accounting policies (see note 3).

The Company has taken advantage of the exemption allowed under section 408 of the Companies Act 2006 and has not presented its own Statement of Comprehensive Income in these financial statements.

The following principal accounting policies have been applied:

  
2.2

Basis of consolidation

The Group's financial statements consolidate those of the parent company and its subsidiaries as of 31 December 2025. 
All transactions and balances between Group companies are eliminated on consolidation, including unrealised gains and losses on transactions between Group companies. Where unrealised losses on intra-group asset sales are reversed on consolidation, the underlying asset is also tested for impairment from a Group perspective. Amounts reported in the financial statements of subsidiaries have been adjusted where necessary to ensure consistency with the accounting policies adopted by the Group.
Profit or loss and other comprehensive income of subsidiaries acquired or disposed of during the year are recognised from the effective date of acquisition, or up to the effective date of disposal, as
applicable.

  
2.3

Going Concern

At the time of approving the financial statements, the director has a reasonable expectation that the Company has adequate resources to continue in operational existence for the foreseeable future. Thus the director continues to adopt the going concern basis in preparation of the financial statements. 

Page 17

 
AMAXA LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

 
2.4

Foreign currency translation

Functional and presentation currency

The Company's functional and presentational currency is Euros.

Transactions and balances

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions.

At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

On consolidation, the results of overseas operations are translated into Euros at rates approximating to those ruling when the transactions took place. All assets and liabilities of overseas operations are translated at the rate ruling at the reporting date. Exchange differences arising on translating the opening net assets at opening rate and the results of overseas operations at actual rate are recognised in other comprehensive income.

 
2.5

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Group and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Sale of goods

Revenue from the sale of goods is recognised when all of the following conditions are satisfied:
the Group has transferred the significant risks and rewards of ownership to the buyer;
the Group retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the Group will receive the consideration due under the transaction; and
the costs incurred or to be incurred in respect of the transaction can be measured reliably.

  
2.6

Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.
Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.
 

Page 18

 
AMAXA LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

 
2.7

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.8

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the balance sheet date in the countries where the Company and the Group operate and generate income.

Deferred tax balances are recognised in respect of all timing differences that have originated but not reversed by the balance sheet date, except that:
The recognition of deferred tax assets is limited to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits; and
Any deferred tax balances are reversed if and when all conditions for retaining associated tax allowances have been met.

Deferred tax balances are not recognised in respect of permanent differences except in respect of business combinations, when deferred tax is recognised on the differences between the fair values of assets acquired and the future tax deductions available for them and the differences between the fair values of liabilities acquired and the amount that will be assessed for tax. Deferred tax is determined using tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


 
2.9

Intangible assets

Intangible assets are initially recognised at cost. After recognition, under the cost model, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

All intangible assets are considered to have a finite useful life. If a reliable estimate of the useful life cannot be made, the useful life shall not exceed ten years.

 The estimated useful lives range as follows:

Patents
-
10
years

Page 19

 
AMAXA LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

 
2.10

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

At each reporting date the Group assesses whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is determined which is the higher of its fair value less costs to sell and its value in use. An impairment loss is recognised where the carrying amount exceeds the recoverable amount.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Long-term leasehold property
-
6%
Plant and machinery
-
20%
Motor vehicles
-
20%
Other fixed assets
-
20%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
2.11

Valuation of investments

Investments in subsidiaries are measured at cost less accumulated impairment.

The investments are assessed impairment at each reporting date and any impairment losses or reversals of impairment losses are immediately recognised in profit or loss. 
A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefit from its activities. 

  
2.12

Stocks

Stocks held for distribution at no or nominal consideration are measured at the lower of cost and replacement cost, adjusted where applicable for any loss of service potential.Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

 
2.13

Debtors

Short-term debtors are measured at transaction price, less any impairment. Loans receivable are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method, less any impairment.

Page 20

 
AMAXA LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

2.Accounting policies (continued)

 
2.14

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

In the Consolidated Statement of Cash Flows, cash and cash equivalents are shown net of bank overdrafts that are repayable on demand and form an integral part of the Group's cash management.

 
2.15

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.16

Financial instruments

The Group has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

The Group has elected to apply the recognition and measurement provisions of IFRS 9 Financial Instruments (as adopted by the UK Endorsement Board) with the disclosure requirements of Sections 11 and 12 and the other presentation requirements of FRS 102.

Financial instruments are recognised in the Group's Balance Sheet when the Group becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include trade and other debtors, cash and bank balances, are initially measured at their transaction price (adjusted for transaction costs except in the initial measurement of financial assets that are subsequently measured at fair value through profit and loss) and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The Group's cash and cash equivalents, trade and most other debtors due with the operating cycle fall into this category of financial instruments.

Other financial assets

Other financial assets, which includes investments in equity instruments which are not classified as subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the recognised transaction price. Such assets are subsequently measured at fair value with the changes in fair value being recognised in the profit or loss. Where other financial assets are not publicly traded, hence their fair value cannot be measured reliably, they are measured at cost less impairment.

Impairment of financial assets

At the end of each reporting period financial assets measured at amortised cost are assessed for
Page 21

 
AMAXA LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

2.Accounting policies (continued)


2.16
Financial instruments (continued)

objective evidence of impairment. If an asset is impaired the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss. 

Financial assets are impaired when events, subsequent to their initial recognition, indicate the estimated future cash flows derived from the financial asset(s) have been adversely impacted. The impairment loss will be the difference between the current carrying amount and the present value of the future cash flows at the asset(s) original effective interest rate.

If there is a favourable change in relation to the events surrounding the impairment loss then the impairment can be reviewed for possible reversal. The reversal will not cause the current carrying amount to exceed the original carrying amount had the impairment not been recognised. The impairment reversal is recognised in the profit or loss.

Impairment losses on financial assets are recognised using the expected credit loss (ECL) model at each reporting date. Expected credit losses represent a probability-weighted estimate of credit losses and incorporate historical experience, current conditions and forward-looking information, including macroeconomic factors, discounted at the asset’s original effective interest rate.

For trade debtors and contract assets, the simplified approach is applied and lifetime expected credit losses are recognised from initial recognition.

For other financial assets, a loss allowance equal to 12-month expected credit losses is recognised on initial recognition. Where credit risk has increased significantly since initial recognition, or where the asset is credit-impaired, lifetime expected credit losses are recognised.

Loss allowances are recognised in profit or loss through an allowance account and are reversed where appropriate if credit risk improves, subject to the carrying amount not exceeding the amount that would have been recognised had no impairment occurred.

Basic financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Group after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other creditors, bank loans, other loans and loans due to fellow group companies are initially measured at their transaction price (adjusting for transaction costs except in the initial measurement of financial liabilities that are subsequently measured at fair value through profit and loss). When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future payments discounted at a market rate of interest, discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade creditors are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade creditors are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade creditors are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.
Page 22

 
AMAXA LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

2.Accounting policies (continued)


2.16
Financial instruments (continued)


Derecognition of financial instruments

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the Group transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the Group will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the Group's contractual obligations expire or are discharged or cancelled.

 
2.17

Dividends

Equity dividends are recognised when they become legally payable. Interim equity dividends are recognised when paid. Final equity dividends are recognised when approved by the shareholders at an annual general meeting.

Page 23

 
AMAXA LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

3.


Judgments in applying accounting policies and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.
Useful lives of tangible fixed assets 
The cost of tangible fixed assets is depreciated over its estimated useful economic life. Management estimates the useful lives of these tangible assets to vary. Changes in the expected level of usage could impact on the useful economic lives and the residual values of these assets; therefore, future depreciation charges could be revised. 
Stock 
The company writes down stock to net realisable value based on an estimate of the realisable value of stock. Written down stock is recorded where events or changes in circumstances indicate that the balances may not be realised. The identification of write-downs requires the use of judgement and estimates. Where the expectation is different from the original estimate or judgement, such difference will impact the carrying value of stock and write-downs of stock in the periods in which such estimates or judgements have been changed.
Bad debts
At each reporting date, the Company reviews the receivables to assess whether an impairment loss should be recorded in the income statement. Impairment of receivables is assessed individually for each receivable. Impairment is calculated on an individual basis depending on delinquencies and case specific analysis. When assessing the requirement for such a provision, management consider factors including the current credit rating of the customer, the ageing profile of the debt and previous experience.

Page 24

 
AMAXA LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

4.


Turnover

An analysis of turnover by class of business is as follows:


18 months ending 31 December
30 June
2025
2024

Sales commission and Marketing Services
937,148
506,143

Sale of pharmaceutical goods
26,371,267
15,382,287

27,308,415
15,888,430


18 months ending 31 December
30 June
2025
2024

United Kingdom
27,308,415
15,888,430

27,308,415
15,888,430



5.


Other operating income

18 months ending 31 December
30 June
2025
2024

Other operating income
27,898
7,517

27,898
7,517


Page 25

 
AMAXA LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

6.


Operating profit

The operating profit is stated after charging:

18 months ending 31 December
30 June
2025
2024

Stock written off
665,110
251,086

Exchange differences
-
10,500

Exchange differences
49,315
8,825

Other operating lease rentals
95,844
32,583

Depreciation and amortisation
150,792
92,090

Due to an accident, stock worth £665,110 (2024: £251,086) was damaged and hence written off. Stock worth Nil (2024: £10,500) was charged to cost of sales as the stock had reached its expiration date. 


7.


Auditors' remuneration

During the 18 months, the Group obtained the following services from the Company's auditors:


18 months ending 31 December
30 June
2025
2024

Fees payable to the Company's auditors for the audit of the consolidated and Parent Company's financial statements
22,090
14,674

Page 26

 
AMAXA LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

8.


Employees

Staff costs, including director's remuneration, were as follows:


Group
18 months ending 31 December
Group
30 June
Company
18 months ending 31 December
Company
30 June
2025
2024
2025
2024


Wages and salaries
1,906,512
576,981
1,112,539
455,272

Social security costs
329,001
166,055
329,001
138,263

2,235,513
743,036
1,441,540
593,535


The average monthly number of employees, including the director, during the 18 months was as follows:



Group
Group
Company
Company
18 months ending 31 December
         30 June
18 months ending 31 December
         30 June
        2025
        2024
        2025
        2024
            No.
            No.
            No.
            No.









Average number of employees
30
30
20
20


9.


Director's remuneration

18 months ending 31 December
30 June
2025
2024

Director's emoluments
93,169
58,817

93,169
58,817


Page 27

 
AMAXA LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

10.


Interest payable and similar expenses

18 months ending 31 December
30 June
2025
2024


Other loan interest payable
-
12,131

-
12,131


11.


Taxation


18 months ending 31 December
30 June
2025
2024

Corporation tax


Current tax on profits for the year
932,555
502,143


932,555
502,143


Total current tax
932,555
502,143

Deferred tax

Total deferred tax
-
-


932,555
502,143
Page 28

 
AMAXA LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025
 
11.Taxation (continued)


Factors affecting tax charge for the 18 months/year

The tax assessed for the 18 months/year is higher than (2024 - higher than) the standard rate of corporation tax in the UK of 25% (2024 - 25%). The differences are explained below:

18 months ending 31 December
30 June
2025
2024


Profit on ordinary activities before tax
3,536,409
1,901,612


Profit on ordinary activities multiplied by standard rate of corporation tax in the UK of 25% (2024 - 25%)
884,102
475,403

Effects of:


Expenses not deductible for tax purposes, other than goodwill amortisation and impairment
287
580

Capital allowances for 18 months/year in excess of depreciation
32,765
21,936

Unrelieved loss on foreign subsidiaries
15,401
4,224

Total tax charge for the 18 months/year
932,555
502,143


12.


Dividends

31 December
30 June
2025
2024


Dividends
323,156
346,256

323,156
346,256


13.


Parent company profit for the year

The Company has taken advantage of the exemption allowed under section 408 of the Companies Act 2006 and has not presented its own Statement of Comprehensive Income in these financial statements. The profit after tax of the parent Company for the 18 months/year was 2,656,450 (2024 - 1,413,319).

Page 29

 
AMAXA LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

14.


Intangible assets

Group







Patents




Cost


At 1 July 2024
25,431


Additions
30,054



At 31 December 2025

55,485



Amortisation


At 1 July 2024
2,537


Charge for the 18 months on owned assets
8,297



At 31 December 2025

10,834



Net book value



At 31 December 2025
44,651



At 30 June 2024
22,894


Page 30

 
AMAXA LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025
 
           14.Intangible assets (continued)

Company






Patents




Cost


At 1 July 2024
25,086


Additions
30,054



At 31 December 2025

55,140



Amortisation


At 1 July 2024
2,509


Charge for the year
8,271



At 31 December 2025

10,780



Net book value



At 31 December 2025
44,360



At 30 June 2024
22,577

Page 31

 
AMAXA LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

15.


Tangible fixed assets

Group



Land & Buildings
Plant and machinery
Motor vehicles
Other fixed assets
Total




Cost or valuation


At 1 July 2024
1,331,241
48,536
-
687
1,380,464


Additions
-
12,867
1,435
3,481
17,783


Disposals
-
-
-
(84)
(84)



At 31 December 2025

1,331,241
61,403
1,435
4,084
1,398,163



Depreciation


At 1 July 2024
205,765
18,544
-
687
224,996


Charge for the 18 months on owned assets
119,812
19,202
-
3,481
142,495


Disposals
-
-
-
(84)
(84)



At 31 December 2025

325,577
37,746
-
4,084
367,407



Net book value



At 31 December 2025
1,005,664
23,657
1,435
-
1,030,756



At 30 June 2024
1,125,476
29,992
-
-
1,155,468




The net book value of land and buildings may be further analysed as follows:


31 December
30 June
2025
2024

Long leasehold
1,005,665
1,125,476

1,005,665
1,125,476


Page 32

 
AMAXA LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

           15.Tangible fixed assets (continued)


Company









Land & Buildings
Plant and machinery
Total


Cost or valuation


At 1 July 2024
1,331,241
48,534
1,379,775


Additions
-
4,730
4,730



At 31 December 2025

1,331,241
53,264
1,384,505



Depreciation


At 1 July 2024
205,765
18,544
224,309


Charge for the 18 months on owned assets
119,812
15,980
135,792



At 31 December 2025

325,577
34,524
360,101



Net book value



At 31 December 2025
1,005,664
18,740
1,024,404



At 30 June 2024
1,125,476
29,990
1,155,466





The net book value of land and buildings may be further analysed as follows:


31 December
30 June
2025
2024

Long leasehold
1,005,665
1,125,476

1,005,665
1,125,476


Page 33

 
AMAXA LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

16.


Fixed asset investments

Company








Investments in subsidiary companies




Cost or valuation


At 1 July 2024
1,420



At 31 December 2025
1,420




During the year ending 30 June 2024, the Company disposed off its investments in Amaxa LLC (Ukraine) for nil value. It acquired investmen in Amaxa East Europe Services LLC (Ukraine) for €1,420. There are no changes in 2025.


Subsidiary undertakings


The following were subsidiary undertakings of the Company:

Name

Registered office

Class of shares

Holding

Amaxa East Europe Services LLC
Ukraine
Ordinary
100%
Amaxa International Operations FZ-LLC
UAE
Ordinary
100%

The aggregate of the share capital and reserves as at 31 December 2025 and the profit or loss for the 18 months ended on that date for the subsidiary undertakings were as follows:

Name
Aggregate of share capital and reserves
Profit/(Loss)

Amaxa East Europe Services LLC
22,717
7,448

Amaxa International Operations FZ-LLC
(61,045)
(43,958)

Page 34

 
AMAXA LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

17.


Stocks

Group
31 December
Group
30 June
Company
31 December
Company
30 June
2025
2024
2025
2024

Finished goods and goods for resale
1,165,437
2,363,493
1,165,116
2,363,493

1,165,437
2,363,493
1,165,116
2,363,493


The difference between purchase price or production cost of stocks and their replacement cost is not material.


18.


Debtors

Group
31 December
Group
30 June
Company
31 December
Company
30 June
2025
2024
2025
2024


Trade debtors
6,923,461
4,109,265
6,918,187
4,107,810

Other debtors
18,580
99,128
72,795
151,863

Prepayments and accrued income
55,157
-
55,157
-

6,997,198
4,208,393
7,046,139
4,259,673


Other debtors for the Company include loan to subsidiary of €59,605 ($70,000), carrying an interest rate of 4% p.a. and repayable by 31 December 2026.



19.


Cash and cash equivalents

Group
31 December
Group
30 June
Company
31 December
Company
30 June
2025
2024
2025
2024

Cash at bank and in hand
4,825,338
3,571,490
4,754,840
3,551,515

4,825,338
3,571,490
4,754,840
3,551,515


Page 35

 
AMAXA LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

20.


Creditors: Amounts falling due within one year

Group
31 December
Group
30 June
Company
31 December
Company
30 June
2025
2024
2025
2024

Trade creditors
311,940
477,506
264,310
525,651

Corporation tax
184,940
-
183,618
-

Other taxation and social security
2,863
2,748
2,859
2,748

Other creditors
-
177,844
-
177,844

Accruals and deferred income
604,297
-
604,297
-

1,104,040
658,098
1,055,084
706,243


Amounts owed to related party of €1,349,111 was paid in full during the year ending 30 June 2024.
Other creditors include dividends payable of Nil (2024:€176,940) outstanding as at the year end.


21.


Share capital

31 December
30 June
2025
2024
Allotted, called up and fully paid



40,000 (2024 - 40,000) Ordinary shares of £1.00each
44,008
44,008



22.


Reserves

Foreign exchange reserve

Foreign exchang reserve comprises of exchange differences arising on translation of financial results of the subsidiary to the Group's presentational and functional currency.

Profit and loss account

Profit and loss account comprises of distributable reserves.

Page 36

 
AMAXA LTD
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE 18 MONTHS ENDED 31 DECEMBER 2025

23.


Post balance sheet events

The Group continues to operate normally; however, it remains exposed to risks arising from the ongoing military conflict in Ukraine, which continues to be a significant market. During the year, the Group maintained its strategic focus on expanding into Central Asian markets. This expansion, together with the successful launch of new products and increased market penetration, has contributed to higher levels of business activity and revenue. Other than the risks associated with the conflict in Ukraine, no significant adverse impacts on the Group's operations have been identified during the reporting period.
Looking ahead, the Group expects to achieve growth of approximately 7% in the 2026 calendar year, supported by continued expansion into Central Asian markets and increasing sales of newly launched products.


24.


Controlling party

The ultimate controlling party and a person with significant control is Miss J Tkachenko.
 


25.


Auditor's liability limitation agreement

An auditors’ limitation of liability agreement has been approved by members for the financial period ended 31 December 2025. The principle terms and conditions are as below:
- The agreement limits the amount of any liability owed to the Company by the auditors in respect of any negligence default, breach of duty or breach of trust, occurring in the course of audit of the Company’s accounts and pursuant to this agreement the auditor may be guilty in relation to the Company.
- The agreement also stipulates the maximum aggregated amount payable in event of any of the circumstances stated above 

 
Page 37